Aurora Cannabis Inc. (TSX:ACB)
Canada · Delayed Price · Currency is CAD 5.38
-0.13 (-2.36%)
At close: Feb 2, 2026
Aurora Cannabis Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 367.13 | 343.29 | 269.64 | 223.8 | 221.34 | 245.25 | |
Revenue Growth (YoY) | 23.89% | 27.32% | 20.48% | 1.11% | -9.75% | -8.73% |
Cost of Revenue | 204.38 | 155.69 | 137.91 | 209.02 | 200.11 | 266.81 |
Gross Profit | 162.74 | 187.61 | 131.73 | 14.78 | 21.23 | -21.56 |
Selling, General & Admin | 164.34 | 153.54 | 143.24 | 156.24 | 162.34 | 174.64 |
Research & Development | 3.45 | 3.68 | 3.57 | 5.77 | 10.39 | 11.45 |
Operating Expenses | 189.6 | 179.22 | 171.5 | 202.37 | 235.09 | 255.5 |
Operating Income | -26.86 | 8.38 | -39.78 | -187.59 | -213.86 | -277.06 |
Interest Expense | -8.49 | -8.42 | -13.8 | -44.46 | -71.81 | -66.44 |
Interest & Investment Income | 9.01 | 11.51 | 12.82 | 14.91 | 4.51 | 5.75 |
Earnings From Equity Investments | - | - | - | 0.05 | -0.29 | -0.51 |
Currency Exchange Gain (Loss) | 11.08 | 11.44 | -0.42 | 8.87 | -0.3 | -3.38 |
Other Non Operating Income (Expenses) | 5.79 | 7.87 | 14.77 | 14.93 | 55.61 | -2.79 |
EBT Excluding Unusual Items | -9.47 | 30.78 | -26.4 | -193.28 | -226.15 | -344.43 |
Merger & Restructuring Charges | -3.44 | -3.44 | -6.83 | -17.43 | -19.62 | -6.77 |
Impairment of Goodwill | - | - | - | - | -914.28 | -33.76 |
Gain (Loss) on Sale of Investments | 0.68 | 0.68 | - | -4.59 | -5.48 | -1.24 |
Gain (Loss) on Sale of Assets | 0.5 | 0.5 | 1.16 | 3.12 | 0.37 | 11.12 |
Asset Writedown | -32.99 | -0.7 | -36.9 | -570.82 | -544.04 | -293.26 |
Legal Settlements | 0.01 | 0.01 | -1.72 | -3.58 | -1.23 | -46.19 |
Other Unusual Items | -7.45 | -7.45 | 13.06 | -30.21 | -9.7 | 14.74 |
Pretax Income | -52.17 | 20.38 | -57.64 | -816.8 | -1,720 | -699.8 |
Income Tax Expense | 9.5 | 4.62 | -0.55 | -16.55 | -2.14 | -6.32 |
Earnings From Continuing Operations | -61.67 | 15.76 | -57.08 | -800.25 | -1,718 | -693.48 |
Earnings From Discontinued Operations | -0.2 | -14.17 | -12.24 | -23.67 | - | -1.61 |
Net Income to Company | -61.87 | 1.59 | -69.33 | -823.91 | -1,718 | -695.09 |
Minority Interest in Earnings | 4.61 | 0.68 | 3.74 | 7.29 | 0.36 | 1.46 |
Net Income | -57.26 | 2.27 | -65.58 | -816.63 | -1,718 | -693.63 |
Net Income to Common | -57.26 | 2.27 | -65.58 | -816.63 | -1,718 | -693.63 |
Shares Outstanding (Basic) | 56 | 55 | 43 | 30 | 21 | 17 |
Shares Outstanding (Diluted) | 56 | 56 | 43 | 30 | 21 | 17 |
Shares Change (YoY) | 6.92% | 28.69% | 42.03% | 41.60% | 27.08% | 74.79% |
EPS (Basic) | -1.03 | 0.04 | -1.52 | -26.84 | -79.92 | -41.01 |
EPS (Diluted) | -1.03 | 0.04 | -1.52 | -26.84 | -79.92 | -41.01 |
Free Cash Flow | -18.31 | -2.85 | -85.34 | -162.61 | -142.48 | -263.66 |
Free Cash Flow Per Share | -0.33 | -0.05 | -1.97 | -5.34 | -6.63 | -15.59 |
Gross Margin | 44.33% | 54.65% | 48.85% | 6.61% | 9.59% | -8.79% |
Operating Margin | -7.32% | 2.44% | -14.75% | -83.82% | -96.62% | -112.97% |
Profit Margin | -15.60% | 0.66% | -24.32% | -364.88% | -776.01% | -282.82% |
Free Cash Flow Margin | -4.99% | -0.83% | -31.65% | -72.66% | -64.37% | -107.51% |
EBITDA | -3.33 | 30.66 | -7 | -135 | -127.04 | -185.17 |
EBITDA Margin | -0.91% | 8.93% | -2.60% | -60.32% | -57.40% | -75.50% |
D&A For EBITDA | 23.53 | 22.28 | 32.78 | 52.59 | 86.82 | 91.89 |
EBIT | -26.86 | 8.38 | -39.78 | -187.59 | -213.86 | -277.06 |
EBIT Margin | -7.32% | 2.44% | -14.75% | -83.82% | -96.62% | -112.97% |
Effective Tax Rate | - | 22.66% | - | - | - | - |
Revenue as Reported | 367.13 | 343.29 | 269.64 | 223.8 | 221.34 | 245.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.